We explore real-life reformation here in this informed, online community.
If Pharma made airplanes there would be airplane crashes every single day and Pharma would blame the people who never fly.
Sudden Aviation Death Syndrome (SADS) would be the label used to describe those killed in the daily airplane crashes which would always be considered a coincidence.
The CDC would strongly recommend that all children fly 90 times before their 18th birthday and blue states would require proof of said flights to attend school; even if you have been in a previous crash there would be no exemptions to the mandated 90 flights.
Anderson Cooper would vilify anyone who took fewer than five flights a year.
The National Transportation Safety Board would assure us that planes have always crashed every day — it was just better awareness that made people think things had gotten worse — while doing absolutely nothing to improve airline safety.
Academics would conduct elaborate studies on “overcoming airplane crash hesitancy.”
The mainstream media would feature endless commercials for medications to treat burns and lost limbs from airplane crashes, complete with singing and dancing spokespeople who are always smiling.
Pharma would make record earnings every year because more crashes mean they need to make more planes!
Wall Street would applaud their visionary business model.
(Nota bene for anyone who thinks that this analogy is facetious: 300 children now develop autism in the United States every day, which is more than the seating capacity of the average domestic airplane flight.)
Dr. Toby Rogers
The FDA has rejected its strongest safety warning for Covid mRNA vaccines despite acknowledging that children were killed by the products.
This news surfaced during a televised Bloomberg interview with FDA Commissioner Marty Makary, who said the agency has “no plans” to apply its strongest safety warning to Covid mRNA vaccines.
In that interview, Makary confirmed that the FDA’s own safety and epidemiology centre had formally recommended a boxed warning — a step reserved, under FDA rules, for drugs with “special problems, particularly ones that may lead to death or serious injury.”
